Rep. Eshoo Introduces Second Biosimilars Bill in House

Rep. Anna Eshoo (D-Calif.) introduced a biosimilars bill in the House Tuesday that will compete with the legislation introduced a week ago by Rep. Henry Waxman (D-Calif.), chairman of the House Energy and Commerce Committee. Both bills would create the first U.S. approval pathway for follow-on biologics. The bills differ in areas such as length of exclusivity for innovators and the need for guidance documents.
Drug Industry Daily